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Abstract
Background: Rodent models have been used extensively to study mammary gland development and for studies
of toxicology and carcinogenesis. Mammary gland gross morphology can visualized via the excision of intact
mammary gland chains following fixation and staining with carmine using a tissue preparation referred to as a
whole mount. Methods are described for the automated collection of digital images from an entire mammary
gland whole mount and for the interrogation of digital data using a “masking” technique available with Image-
Pro
® plus image analysis software (Mediacybernetics. Silver Spring, MD).
Results: Parallel to mammographic analysis in humans, measurements of rodent mammary gland density were
derived from area-based or volume-based algorithms and included: total circumscribed mammary fat pad mass,
mammary epithelial mass, and epithelium-free fat pad mass. These values permitted estimation of absolute mass of
mammary epithelium as well as breast density. The biological plausibility of these measurements was evaluated in
mammary whole mounts from rats and mice. During mammary gland development, absolute epithelial mass
increased linearly without significant changes in mammographic density. Treatment of rodents with tamoxifen, 9-
cis-retinoic acid, or ovariectomy, and occurrence of diet induced obesity decreased both absolute epithelial mass
and mammographic density. The area and volumetric methods gave similar results.
Conclusions: Digital image analysis can be used for screening agents for potential impact on reproductive toxicity
or carcinogenesis as well as for mechanistic studies, particularly for cumulative effects on mammary epithelial mass
as well as translational studies of mechanisms that explain the relationship between epithelial mass and cancer risk.
Background
Rodent models have been used extensively to study
mammary gland development and for investigations of
many aspects of reproductive toxicology and breast car-
cinogenesis [1,2]. Mammary gland development occurs
postnatally and is affected by initiation of ovarian func-
tion as occurs in humans at the time of menarche [3].
The development of the rodent mammary gland has
been described in detail [3-5]. However, while represen-
tative images of mammary gland gross morphology are
frequently reported in the literature, the actual quantifi-
cation of changes in gross morphology is uncommon
and rarely have such analyses been extended to the
entire mammary gland rather than a small representa-
tive area. The work reported herein describes a techni-
que for automated collection of digital images of rodent
mammary glands excised as a mammary gland chain.
While the mammary glands of rodents occur symmetri-
cally in pairs and are divided into those that occur in
the cervical-thoracic region and the abdominal-inguinal
region, visualization of the cervical-thoracic glands in
either the rat or the mouse is hindered by a band of
muscle that lies interspersed between the glands. The
muscle is difficult to uniformly remove and thus renders
excised chains impossible to digitally imagine without
confounding of results due to residual adhering muscle.
However, no muscle bands are present in the abdom-
inal-inguinal mammary gland chain of either species
and for that reason the abdominal-inguinal chain is tra-
ditionally imaged by investigators. The abdominal-ingu-
inal mammary gland chain is the focus of the work
reported.
Mammary gland morphology is studied indirectly in
women via mammography. Other than the use of mam-
mography for the early detection of small pathologies
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mammograms are also used to estimate breast density, i.
e. the ratio of radiodense fibroglandular breast tissue to
the total amount of breast tissue present; non glandular,
radiolucent breast tissue is also determined. Breast den-
sity is an independent risk factor for breast cancer [6].
In reality there are four methods for estimating breast
density in humans[7], but the two methods that use
computer-assisted image analysis to determine area or
volume of glandular tissue are parallel to the digital ana-
lyses reported herein which also measure mammary
epithelial mass in absolute terms or expressed as a per-
cent area or percent volume. The similarities in methods
are remarkable. In the human, the total area or volume
of the breast is determined by the physical contour of
the breast which can be reproducibly demarcated. In the
rodent the contour of the mammary fat pad is opera-
tionally defined via a line circumscribed around
the most distal end buds of the mammary gland chain
(Figure 1).
Methods
Abdominal inguinal mammary gland chains were
excised at necropsy and prepared as whole mounts as
described by Thompson et al [8]. The work followed
ethical guidelines approved by the Colorado State Uni-
versity Animal Care and Use Committee. The left chain
was fixed in methacarn (24 hrs) and the right chain
fixed in 10% neutral buffered formalin (24 hrs). Fixed
mammary whole mounts were dehydrated using a series
of graded ethanols, cleared in xylene, hydrated using a
series of graded ethanols and stained in modified
Mayer’s carmalum (0.4% carmine in 1.0% aluminum
potassium sulfate) for 3 days. Whole mounts were
rinsed in tap water to remove excess carmine stain,
dehydrated using a series of graded ethanols and cleared
in xylene.
Cleared whole mounts were prepared using a modified
protocol described by Wellings et al [9]. Whole mounts
were placed in a 4 × 6 inch 4.5 mil thick kapak
® (3 M,
St. Paul, MN) heat seal bags, filled with 20 ml of methyl
salicylate (Sigma. St Louis, MO) and the bags crimped
at the top using a kapak
® (3 M) heat sealer. All alcohols
and solvents were used under a chemical fume hood. In
addition, a NIOSH approved air-purifying unit (3 M)
was worn during dispensing and handling of methyl sali-
cylate to avoid unnecessary exposure.
Air bubbles were removedb yp l a c i n gt h eb a g g e d
whole mount on a flat surface and forcing the air bub-
bles to the periphery of the whole mount using slight
finger pressure. The bagged whole mounts were placed
vertically in the heat sealer. Residual air and excess
methyl salicylate was displaced to the top by applying
slight pressure to the bottom half of the bag containing
the whole mount. The bag was crimped in the middle
with the whole mount in the bottom of the bag and the
residual air and excess methyl salicylate at the top. The
bag was cut along the midline to separate the two
halves.
Digital images of the mammary gland whole mounts
were captured using a semi-automated image acquisi-
tion system (North Central Instruments, Plymouth,
MN). The components of this system included a 3.0
megapixel CMOS digital camera (Clemex Technologies,
Inc. Longueuil, Canada) mounted on a Leica Z16 APO
monocular zoom lens 16:1 with a magnification range
of 0.57 - 9.2x. The camera and lens were mounted on a
Leica Z motor attached to a transmitted light base with
a 100 × 100 mm motorized stage (Clemex Technolo-
gies, Inc.). An X-Y control box and joystick (Clemex
Technologies, Inc.) in conjunction with a Pentium 4
desktop PC (Dell, Round Rock, TX) and Captiva v4.0
software (Clemex Technologies, Inc.) were used for
image capture.
Whole mounts were placed on a 6 mm thick sheet of
white acrylic plastic (Gagne, Inc. Johnson City, NY)
mounted on top of the motorized stage to act as a diffu-
ser. Specimens were trans-illuminated using a 20 V/150
W halogen lamp light source (Volpi, Auburn, NY) with
daylight filter mounted at the rear of the base. A series
of Z-stack images were automatically captured at
10&3215; magnification using the motorized stage in
conjunction with the Captiva 4.0 software (Clemex
Technologies, Inc.) and × Y controller. The software
seamlessly merged tiled Z-stack images together to form
a single uniformly focused composite image based on a
best contrast algorithm. Resulting images were saved as
TIF files.
Image-Pro
® plus 4.5 (Mediacybernetics. Silver Spring,
MD) image analysis software was used to quantify
images according to a modified version of a protocol
described by Thompson et al [10]. A composite image
of a stage micrometer was captured under the same
conditions as the whole mounts. This image was used to
calibrate the area measurements in units of cm
2. A stan-
dard optical density curve relating gray level (0-255) to
intensity (0 - 2.4) was used to measure ΣOD. An Image
Pro macro was written to simplify image analysis. This
not only increased the speed of analysis, but also elimi-
nated potential errors.
The macro converted the original color images (Figure
1A) to 8 bit gray scale. Lymph nodes were selected
using the irregular area of interest (AOI) tool wand
option (Figure 1B). A mask of the selected lymph node
areas was created and an “or” image operation process
was applied to extract the lymph nodes from the gray
scale images. Mammary gland epithelium was manually
circumscribed using the irregular AOI tool trace option
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ples were excluded from the AOI (Figure 1C). The AOI
was removed and the image was “flattened”, a digital fil-
tering process that decreases the variation in the inten-
sity of background pixels, which is essential when
attempting to properly threshold areas within an image
that contain similar intensities, e.g. differentiating mam-
mary epithelia from interductal fat pad within a whole
mount (Figure 1D). High contrast was applied to the
flattened image to enhance visualization of dense areas
and the AOI was reapplied (Figure 1E). A 0-254 gray
level selection threshold, marked in red was applied to
the AOI (Figure 1F), from which two binary masks were
created, one mask containing non-dense elements
(interductal fat pad) within the AOI and other inverted
mask containing dense elements (mammary epithelia)
within the whole mount AOI (Figure 1G)
An “or” image operation was performed using the gray
scale image (Figure 1C) and the inverted dense area
mask (Figure 1G) to extract only the dense areas (mam-
mary epithelia) from the whole mount (Figure 1H),
from which area and volume estimates of the mammary
epithelia were obtained (Figure 1I). A similar image pro-
cess was applied to the gray scale image (Figure 1C) and
non-dense area mask to extract only non-dense areas
(interductal fat pad) from the whole mount (Figure 1J),
which in turn was used to estimate area and volume of
the interductal fat pad (Figure 1K). The circumscribed
AOI in the original gray scale image (Figure 1C) was
then used to obtain total area and volume estimates,
thus representing combined epithelial and interductal
fad pad measurements of the mammary chain (Figure
1L). All measurements were exported to an Excel
spreadsheet (Microsoft. Redmond, WA) via dynamic
data exchange. Data were then imported into Systat 13
(Systat Software, Inc., Chicago, IL) for statistical analysis.
Results and discussion
The intent of the digital imaging technique described in
the Methods section is to provide a tool to quantify,
modify, and investigate mechanistically mammary
epithelial mass and density. The work reported herein is
a critical first step in achieving that objective and closely
models the methods used to quantify breast density in
women [11]. In the following sections, the digital image
analysis tool for rodent mammary gland was applied to
a number of biological contexts to illustrate usage and
to evaluate the biological plausibility of what is mea-
sured. For each example to which the analysis tool was
applied, potential research applications are discussed.
Mammary gland development
The digital analysis tool was first applied to the develop-
ment of the mammary gland which occurs postnatally
in mammals [3,4]. Female Sprague-Dawley rats were
euthanized at 21, 28, 35, 42, 49, 56 and 63 days of age
(DOA), n = 9/time point. Figure 2 shows representative
mammary gland images at 7 day intervals for this time
course. The hypothesis underlying this experiment was
that the absolute amount of mammary epithelium in the
abdominal-inguinal chain would increase over the time-
frame of the experiment. The amount of mammary
epithelium was quantified using either an area algorithm
or a volume algorithm as is currently done in the analy-
sis of digital images of human mammograms [11-13].
As shown in Table 1, the measurements made in
humans, total fibroglandular mass, mass of non-glandu-
lar tissue, total breast mass, and breast density (fibro-
glandular mass/total breast mass), estimated by the area
or volumetric method, have direct counterparts in the
analysis of rodent tissue. As shown in Figure 3, there
Figure 1 Stepwise example of whole mount digital image
analysis. (A) original color image, (B) image converted to gray scale
and lymph nodes marked, (C) lymph nodes excised and epithelia
circumscribed as an AOI (green). (D) flattened image, (E) high
contrast enhancement applied, (F) setting image threshold, (G)
inverted digital mask, (H) extracted epithelia (I) measured epithelia
(J) extracted interductal fat pad (K) measured interductal fat pad, (L)
total measurement. Bars = 0.5 cm.
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estimating absolute mass of mammary epithelium, with
95% of the variance in the volume measurement being
accounted for in the measurement of area (r
2 =0 . 9 5 ,p
< 0.001 on the log transformed data). For this reason,
the focus of this analysis and the others reported in this
p a p e rw a so nt h ea r e aa l g o r i t h ms i n c ea r e ae s t i m a t e s
have been reported to be more useful in the clinical set-
ting [13]. Total mammary epithelial mass (p <0 . 0 0 1 )
increased with increasing age; whereas, the area asso-
ciated with the interductal fat pad component of the
gland increased from 21 to 49 DOA, but growth rate
was reduced after 49 DOA, perhaps indicting a slowing
of ductal extension while ductal branching increased.
These findings are consistent with the occurrence of
sexual maturation which is manifest as vaginal opening
between 30 and 38 DOA in Sprague Dawley rats and
the occurrence of the first estrous cycle which occurs
between 40 and 45 DOA [2]. Interestingly, mammary
density did not change markedly between 35 and 63
DOA, perhaps due to the limitations in determining
total breast volume as mentioned in the Introduction
section. These data provide evidence that the method of
digital analysis presented herein is quantitative and the
absolute epithelial mass data meet the criteria of biologi-
cal plausibility.
From a research perspective, these data indicate that
this technique could be used to quantify the net cumu-
lative effects of an intervention over time on mammary
epithelial mass, i.e. the net balance between cell prolif-
eration and cell death, as well as how changes in mass
of the non-epithelial component of the mammary fat
pad correspond to the changes in mass that occur in the
epithelial compartment. In this context, the measure-
ment of epithelial density would reflect the complexity
of the growth pattern that was occurring.
Effect of endocrine manipulations
In order to further evaluate biological plausibility, two
experiments were conducted. In the first experiment,
mature female Sprague Dawley rats were bilaterally ovar-
iectomized at 110 DOA. Following ovariectomy, the rats
were maintained for an additional 5 weeks under standard
housing conditions. The hypothesis tested was that mam-
mary gland mass would be reduced in comparison to rats
whose ovaries had not been removed (intact animals).
Representative images from intact and ovariectomized rats
are shown in Figure 4. As shown in Table 2, total mam-
mary epithelial mass was reduced by 33% in ovariecto-
mized rats, (8.14 vs 5.48, p = 0.002). The total area in
which the mammary gland wase n c o m p a s s e dw a sa l s o
reduced, consistent with a reduction in the overall size of
the gland (15.34 vs 11.05, 28% decrease, p < 0.001). How-
ever when epithelial mass was divided by mass of the
entire gland, to estimate breast density, a 6.6% reduction
in density was observed, but the decrease was not statisti-
cally significant (52.9 vs 49.4, p = 0.177). This suggests
that during this short term loss of ovarian hormone func-
tion in the mature rat that the amount of mammary
epithelium was decreasing at a more rapid rate than
epithelial complexity measured as mammary epithelium
mass per square centimeter of mammary gland.
In the second experiment, female Sprague Dawley rats
were administered 1 mg tamoxifen as tamoxifen citrate
in a purified diet beginning at 28 DOA. Rats were trea-
ted for 6 weeks and then euthanized. This dose of
tamoxifen is highly protective against chemically
induced mammary carcinogenesis under these condi-
tions [14]. As summarized in Table 3, tamoxifen treated
rats had a 46.5% reduction in mammary epithelial mass
(8.14 vs 4.37, p < 0.001) and a 24.3% reduction in total
area (15.34 vs 11.06. p < 0.001. Unlike the effects of
ovariectomy, treatment with tamoxifen in this content
reduced breast density from 52.9% vs 39.5%, p <0 . 0 0 1 ,
Figure 2 Time course of rat mammary gland whole mounts. (A)
Stained whole mounts ranging from 21 to 63 days of age (DOA),
bars = 0.5 cm. (B) Area and volume measurements.
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Page 4 of 9Table 1 Area Measurements of Time Course Mammary Gland Whole Mounts
DOA Epithelial
area
(cm
2)
Interductal
fat pad
area
(cm
2)
Total
area
(cm
2)
Epithelial
density
area %
Epithelial volume (∑OD) Interductal
fat pad volume (∑OD)
Total volume (∑OD) Epithelial
density
volume %
21 0.86 ± 0.08
a 0.81 ± 0.07
a 1.62 ± 0.14
a 52.68 ± 1.27
a 6425.5 ± 583.8
a,h 2164.0 ± 211.5
a,h 8570.9 ± 779.2
a,h 75.07 ± 0.83
a,h
28 2.69 ± 0.16
b 1.73 ± 0.15
b 4.36 ± 0.28
b 61.91 ± 1.00
b,h 17225.8 ± 1744.7
b,h,i 3460.6 ± 458.4
b,h,i 20700.6 ± 2168.1
b,h,i 83.47 ± 0.84
b,i
35 4.07 ± 0.31
c 2.63 ± 0.25
c,h 6.53 ± 0.54
c 62.59 ± 0.63
c,h 30042.1 ± 3548.6
c,i,j,k 7178.2 ± 1147.3
c,i,j 37220.3 ± 4692.7
c,i,j,k 81.17 ± 0.51
c,i
42 5.20 ± 0.21
d 3.28 ± 0.18
d,h 8.28 ± 0.37
d 62.89 ± 0.73
d,h 43344.1 ± 3761.8
d,j,l 10286.4 ± 716.4
d,j,k 53630.6 ± 4388.7
d,j,l 80.63 ± 0.71
d,i
49 6.82 ± 0.20
e 5.32 ± 0.20
e,i 11.77 ± 0.32
e 58.00 ± 1.04
e,h 43475.6 ± 4520.7
e,k,l 12114.0 ± 1031.7
e,k 55589.6 ± 5449.1
e,k,l 77.90 ± 0.94
e,h,i
56 8.38 ± 0.23
f,h 5.35 ± 0.15
f,i,j 13.85 ± 0.35
f,h 60.50 ± 0.58
f,h 76073.4 ± 4138.3
f,m 21564.5 ± 1122.4
f,l 97637.8 ± 4899.8
f,m 77.83 ± 0.74
f,h,i
63 9.19 ± 0.32
g,h 5.34 ± 0.09
g,j 14.74 ± 0.38
g,h 62.23 ± 0.66
g,h 88775.5 ± 7127.8
g,m 24786.9 ± 1160.2
g,l 113562.4 ± 8120.4
g,m 77.85 ± 0.75
g,h,i
Values are means ± SEM (n = 9 per DOA). Values in a column with different superscripts are statistically different, p < 0.05 by method of Bonferroni for multiple comparisons.
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9an indication that the complexity of the mammary gland
was reduced by tamoxifen. Both the reduction in mam-
mary gland mass and in mammary gland density are
consistent with these parameters being predictive of
cancer risk as proposed for breast density in human
populations. The comparison between the effects of
ovariectomy and tamoxifen, both of which are protective
against the occurrence of breast cancer show that it is
possible to have a reduction in mammary epithelial
mass with or without a reduc t i o ni nd e n s i t yb a s e do n
our operational definition of determining mass of the
entire mammary gland. From a research perspective,
these findings indicate that the digital analysis of
epithelial density may be of particular value in elucidat-
ing the relationship between breast density and cancer
risk as well as serve a useful purpose in screening com-
pounds for reproductive toxicity, a good example of
which would be environmentally occurring neuroendo-
crine disrupters [15,16].
Effect of 9-cis Retinoic Acid
Dramatic effects in mammary gland development can be
seen in young animals treated with agents such as 9-cis
retinoic acid (Figure 5). Female Sprague Dawley rats
were obtained at 21 DOA and treated with 120 mg 9-cis
retinoic acid per kg purified diet (AIN 93-G). Feeding
experimental diets was initiated at 28 DOA and contin-
ued for 6 weeks at which time rats were euthanized.
While it is clear from Figure 5 that mammary gland size
and complexity were reduced by treatment, the quantifi-
cation of this effect is shown in Table 4. Epithelial mass
(5.442 vs 1.667, p < 0.001) was reduced by 69.4% by
treatment with 9-cis retinoic acid; whereas total mam-
mary gland size was 47.6% lower (9.664 vs 5.064, p <
0.001). When the percent mammary gland density was
computed, it was reduced by 41.7% (56.3 vs 32.8, p <
0.001). This provides yet another perspective from
which to evaluate biological plausibility of the measure-
ment technique. From a research perspective, it is well
known that this retinoid is a strong chemopreventive
agent in the mammary gland at this dietary concentra-
tion [17,18]. This raises the possibility that the digital
assessment tool could be used to screen agents for che-
mopreventive activity as well as to study mechanisms at
the whole tissue level of complexity.
Effect of obesity
There is considerable interest in determining how obe-
sity affects breast cancer risk. In humans, obesity and
increased breast density are both positively correlated
with breast cancer risk but inversely correlated with one
another [13]. The digital analysis procedure was applied
to obese mice to determine how the rodent compares
with the human and to illustrate the use of the
Figure 4 Rat mammary gland whole mounts. (A) Control, (B)
Tamoxifen (1 mg), (C) Ovex. Bars = 0.5 cm.
Figure 3 log transformed regression analysis of mammary
epithelial area and volume.
Table 2 Mammary gland density analysis of
ovariectomized rats
Treatment Epithelial
area
(cm
2)
Interductal
fat pad area
(cm
2)
Total
mammary
gland area
(cm
2)
Epithelial
density
area %
Control
(n = 5)
8.15 ±
0.99
7.20 ± 0.38 15.34 ± 0.77 52.9 ± 4.0
Ovariectomy
(n = 5)
5.48 ±
0.71
5.57 ± 0.28 11.05 ± 0.77 49.4 ± 3.5
p 0.002 < 0.001 < 0.001 0.177
Values are means ± SD
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prone to dietary induced obesity [19,20]. Female mice
were obtained from Jackson Laboratory at 21 DOA and
maintained on either a non obesogenic low fat diet for-
mulation (Research Diets D12329) or a high fat obeso-
genic diet (Research Diets D12331). Diets were fed for
270 days at which time mice were euthanized and mam-
mary glands processed for analysis. Representative whole
mounts from a non-obese and obese mouse are shown
in Figure 6 and the effects of obesity on mammary
epithelial mass and mammary epithelial density are
shown in Table 5. Consistent with other reports, the
body weights of the obese mice were markedly higher
than that of their non-obese counterparts. Mammary
epithelial mass was reduced in obese mice by 20.3%
(1.58 vs 1.98, p = 0.259) but total area was unaffected
(5.161 vs 5.247, p = 0.908). Mammary epithelial density
was reduced by 20.5% (29.9 vs 37.6, p = 0.046), a finding
consistent with reports that obesity is associated with a
r e d u c t i o ni nb r e a s td e n s i t yi nw o m e n[ 1 3 ] .F r o ma
research perspective, this technique affords the opportu-
nity to address numerous research issues. Not only can
questions about the seemingly contradictory roles of
obesity and breast density on cancer risk be investigated
mechanistically, but the technical capability now exists
to quantify the cumulative effects of various engineered
genotypes on mammary epithelial mass and complexity
and to relate those effects to the development of cancer.
General Comments
Just as there are numerous procedures and quality
assurance protocols that are required for the meaningful
interpretation of human mammograms [11], it is essen-
tial that rodent mammary gland chains be properly
excised and spread out so that the digital images and
flattening algorithms used in image analysis are subject
Table 3 Mammary gland density analysis of tamoxifen treated rats
Treatment Epithelial area (cm
2) Interductal fat pad area (cm
2) Total mammary gland area (cm
2) Epithelial density area %
Control
(n = 13)
8.07 ± 0.91 6.98 ± 0.99 15.06 ± 1.51 53.7 ± 4.1
Tamoxifen
(n = 23)
5.77 ± 0.72 6.76 ± 1.08 12.53 ± 1.64 46.2 ± 3.2
p < 0.001 0.538 < 0.001 < 0.001
Values are means ± SD
Figure 5 Rat mammary gland whole mounts. (A) Control, (B) 9-cis Retenoic acid (120 ppm). Bars = 0.5 cm
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are more prone to errors associated with lack of ade-
quate spreading of the mammary gland chain when it is
excised and to issues inherent in defatting and staining
a thick, fatty tissue like the rodent mammary gland. The
major errors in the measurement of area are associated
with either under or overspreading of the mammary
gland during whole mount preparation, but it is our
experience that after training and practice, these errors
are minimal and easily identified by data analysis for sta-
tistical outliers. While error rates appear to be lower for
t h ea r e am e a s u r e m e n t s ,t h ev o l u m e t r i ca p p r o a c ho f f e r s
more information but is probably best used by experi-
enced practitioners. It is also worth noting that metha-
carn fixed whole mounts stained better, cleared better
and had fewer problems associated with tissue detach-
ment from the slides compared to formalin fixed
counterparts.
Limitations
As noted in the Introduction section, whereas in the
human, the total area or volume of the breast is deter-
mined by the physical contour of the breast which can be
reproducibly demarcated, in the rodent, the contour of the
mammary fat pad is operationally defined via a line cir-
cumscribed around the most distal end buds of the mam-
mary gland chain. Clearly, this approach underestimates
total mammary gland fat pad area, but as shown in the
Results and Discussion section, this biases against finding
intervention effects and thus provides the basis for a
robust assessment tool. Another potential limitation is
that stroma is a major contributor to mammographic den-
sity in humans but appears to be substantially less con-
spicuous in the rodent mammary gland. In addition, while
mammographic density in humans can be monitored over
time, the approach described here can only be applied to
excised mammary glands.
Conclusions
The mammary gland digital analysis tool described in
this paper provides a means to characterize the effects
of various genetic manipulations on mammary gland
morphology as well as the effects of environmental con-
taminants such as neuroendocrine disruptors and their
associated reproductive toxicities. The approach also
has potential for the preclinical investigator to conduct
Figure 6 Mouse mammary gland whole mounts. (A) low fat diet,
(B) high fat diet. (C) high resolution view of 0.5 cm
2 area depicted
in panel A (black square). (D) high resolution view of 0.5 cm
2 area
depicted in panel B (black square). Bars = 0.5 cm.
Table 5 Mammary gland density analysis of obese mice
Treatment Epithelial
area
(cm
2)
Interductal
fat pad area
(cm
2)
Total
mammary
gland area
(cm
2)
Epithelial
density
area %
Low fat
(n = 4)
1.98 ±
0.33
3.27 ± 0.23 5.25 ± 0.14 37.65 ± 5.69
High fat
(n = 7)
1.58 ±
0.61
3.58 ± 0.85 5.16 ± 1.40 29.87 ± 5.20
p 0.259 0.492 0.908 0.046
Values are means ± SD
Table 4 Mammary gland density analysis of 9-cis retinoic
acid (120ppm) treated rats
Treatment Epithelial
area
(cm
2)
Interductal
fat pad area
(cm
2)
Total
mammary
gland area
(cm
2)
Epithelial
density
area %
Control
(n = 5)
5.44 ±
0.46
4.22 ± 0.33 9.66 ± 0.55 56.3 ± 2.6
9-cisRA
(n = 5)
1.67 ±
0.34
3.40 ± 0.50 5.06 ± 0.79 32.8 ± 2.9
p < 0.001 0.015 < 0.001 < 0.001
Values are means ± SD
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Page 8 of 9mechanistic studies that have direct translational value
to the clinic. Many questions exist not only about the
most effective manner in which to evaluate and inter-
pret mammographic density in the clinic but also about
the mechanisms that account for the predictive value of
breast density for cancer risk and for explanations of
complex issues such as changes in breast density and
breast cancer risk with aging and the basis for the
effects of adiposity and breast density on breast cancer
risk.
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